Related Experiment Video
Updated: Jun 10, 2025

Reporter-based Growth Assay for Systematic Analysis of Protein Degradation
Published on: November 6, 2014
Mechanism of degrader-targeted protein ubiquitinability
Charlotte Crowe1,2, Mark A Nakasone1,2, Sarah Chandler3
1Centre for Targeted Protein Degradation, School of Life Sciences, University of Dundee, 1 James Lindsay Place, Dundee DD1 5JJ, UK.
Abstract:
Small-molecule degraders of disease-driving proteins offer a clinically proven modality with enhanced therapeutic efficacy and potential to tackle previously undrugged targets. Stable and long-lived degrader-mediated ternary complexes drive fast and profound target degradation; however, the mechanisms by which they affect target ubiquitination remain elusive. Here, we show cryo-EM structures of the VHL Cullin 2 RING E3 ligase with the degrader MZ1 directing target protein Brd4BD2 toward UBE2R1-ubiquitin, and Lys456 at optimal positioning for nucleophilic attack. In vitro ubiquitination and mass spectrometry illuminate a patch of favorably ubiquitinable lysines on one face of Brd4BD2, with cellular degradation and ubiquitinomics confirming the importance of Lys456 and nearby Lys368/Lys445, identifying the "ubiquitination zone." Our results demonstrate the proficiency of MZ1 in positioning the substrate for catalysis, the favorability of Brd4BD2 for ubiquitination by UBE2R1, and the flexibility of CRL2 for capturing suboptimal lysines. We propose a model for ubiquitinability of degrader-recruited targets, providing a mechanistic blueprint for further rational drug design.
Insights
Small-molecule degraders harness E3 ligases to eliminate disease proteins. This study reveals how degrader MZ1 positions Brd4 for ubiquitination, identifying key lysine residues crucial for target degradation.
Area of Science:
- Biochemistry
- Structural Biology
- Drug Discovery
Background:
- Small-molecule degraders are a promising therapeutic strategy targeting disease-driving proteins.
- Understanding the mechanism of target ubiquitination by degrader-mediated complexes is crucial for drug development.
Purpose of the Study:
- To elucidate the structural and mechanistic basis of target ubiquitination by small-molecule degraders.
- To identify key residues and regions involved in the ubiquitination of the target protein Brd4BD2.
Main Methods:
- Cryo-electron microscopy (cryo-EM) to determine the structure of the VHL-Cullin 2 RING E3 ligase complex with degrader MZ1 and target Brd4BD2.
- In vitro ubiquitination assays and mass spectrometry to map ubiquitinable lysine residues.
- Cellular degradation assays and ubiquitinomics to validate key lysine residues in vivo.
Main Results:
- Cryo-EM structures revealed the precise positioning of Brd4BD2 for ubiquitination by UBE2R1-ubiquitin.
- A specific "ubiquitination zone" on Brd4BD2, including Lys456, Lys368, and Lys445, was identified as critical for degradation.
- The study highlights the catalytic efficiency of the degrader and the flexibility of the E3 ligase complex.
Conclusions:
- A mechanistic model for the ubiquitination of degrader-recruited targets was proposed.
- These findings provide a blueprint for the rational design of more effective small-molecule degraders.
- The study advances our understanding of targeted protein degradation mechanisms.
Related Concept Videos
Regulated Protein Degradation
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
The Proteasome
In this pathway, the target proteins are first tagged with small proteins called ubiquitin. This involves participation of a series of enzymes including— E1 (ubiquitin-activating enzyme), E2 (ubiquitin-conjugating enzyme), and E3...
The Proteasome Structure
The proteasome is an...
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein....
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
Export of Misfolded Proteins out of the ER

